Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NIPAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SKP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEPDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHOQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALM2-AKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TSHR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF711 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP83 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MZB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP128 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBEA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBPL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on